These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 28169208)
21. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060 [TBL] [Abstract][Full Text] [Related]
22. Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study. Kim SH; Han DH; Choi GH; Choi JS; Kim KS J Gastrointest Surg; 2019 Mar; 23(3):538-544. PubMed ID: 30112702 [TBL] [Abstract][Full Text] [Related]
23. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Tamandl D; Kaczirek K; Gruenberger B; Koelblinger C; Maresch J; Jakesz R; Gruenberger T Br J Surg; 2009 Aug; 96(8):919-25. PubMed ID: 19591163 [TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis in intrahepatic cholangiocarcinoma. Yamamoto M; Takasaki K; Yoshikawa T Jpn J Clin Oncol; 1999 Mar; 29(3):147-50. PubMed ID: 10225697 [TBL] [Abstract][Full Text] [Related]
25. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054 [TBL] [Abstract][Full Text] [Related]
26. Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma. Si A; Li J; Xiang H; Zhang S; Bai S; Yang P; Zhang X; Xia Y; Wang K; Yan Z; Lau WY; Shi L; Shen F Oncotarget; 2017 Jul; 8(27):44521-44532. PubMed ID: 28562348 [TBL] [Abstract][Full Text] [Related]
27. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. Li DY; Zhang HB; Yang N; Quan Y; Yang GS World J Gastroenterol; 2013 Dec; 19(47):9084-91. PubMed ID: 24379635 [TBL] [Abstract][Full Text] [Related]
28. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis. Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643 [TBL] [Abstract][Full Text] [Related]
29. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? Paik KY; Jung JC; Heo JS; Choi SH; Choi DW; Kim YI J Gastroenterol Hepatol; 2008 May; 23(5):766-70. PubMed ID: 17868336 [TBL] [Abstract][Full Text] [Related]
30. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. Guglielmi A; Ruzzenente A; Campagnaro T; Valdegamberi A; Bagante F; Bertuzzo F; Conci S; Iacono C J Gastrointest Surg; 2013 Nov; 17(11):1917-28. PubMed ID: 24048613 [TBL] [Abstract][Full Text] [Related]
31. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience. Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755 [TBL] [Abstract][Full Text] [Related]
32. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477 [TBL] [Abstract][Full Text] [Related]
33. Intrahepatic cholangiocarcinoma in Korea. Kim HJ; Yun SS; Jung KH; Kwun WH; Choi JH J Hepatobiliary Pancreat Surg; 1999; 6(2):142-8. PubMed ID: 10398901 [TBL] [Abstract][Full Text] [Related]
34. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148 [TBL] [Abstract][Full Text] [Related]
37. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443 [TBL] [Abstract][Full Text] [Related]
38. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma. Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802 [TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539 [TBL] [Abstract][Full Text] [Related]